CNBX Pharmaceuticals Inc (CNBX)

[Otcinvesting]

CNBX Commercialization will commence in March 2017, when 10 first patients' liquid biopsies will be tested using this technology. The company plans to make this service available to cancer patients in Canada, Europe and the USA, under local medical cannabis regulations in each country and state, by the end of the year. Itamar Borochov, CEO of Cannabics Pharmaceuticals, says "We are the first company in the world to offer cancer patients personalized cannabinoid anti-tumor diagnostics. We are excited to be pioneers in the nexus of cannabis and personalized cancer treatments".


http://www.prnewswire.com/news-releases/cannabics-pharmaceuticals-announces-initial-commercialization-of-cannabinoids-based-personalized-diagnostics-for-cancer-patients-300403359.html